AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Mark Chillingworth
R&D specialist acquired to bolster Thomson Pharma
Mark Chillingworth
Thomson Scientific has acquired a highly specialised pharmaceutical information provider to add R&D benchmarking information and consulting to Thomson Pharma.
Epsom-based Centre for Medicines Research International (CMR) has been acquired for an undisclosed sum.
"Lately there has been an interest by pharmaceutical companies to compare the R&D performance of the industry with their own and that of their close rivals," said Peter Joshua, CMR VP, of the information it adds to the Pharma portfolio. CMR collects information directly from the pharmaceutical industry, strips out details of identity and provides in-depth analysis on R&D trends back to the industry.
"The pharmaceutical industry is spending $60bn per annum trying to find new medicine, but in the last ...
Source: HighBeam Research, R&D specialist aquired to bolster Thomson Pharma.(Centre for...